Official UK procurement notice
NP47822 Multiple Sclerosis Medicines
Authority: The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS") (NHS & healthcare)·Consortium: 2 public authorities
What is being bought
Published requirement descriptionSupply of Multiple Sclerosis Medicines to NHS Scotland
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 6 suppliers · 4 bids received (0.7 per place) · 4 appointed
The lotProcurement structure
single lot · value publishedLot #1Supply of Multiple Sclerosis Medicines to NHS ScotlandAwardedRenewalPublished value£17,031,052
Supply of Multiple Sclerosis Medicines to NHS Scotland. The Authority has awarded the Framework Agreement as a multi supplier framework agreement per line to four (4) Framework Participants.
The medicines awarded to the Framework Agreement are as follows:
- Glatiramer acetate injection
- Interferon beta-1a
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Technical (Supply Chain): 5%
- price: 95%
Published award criteria (2)
- Technical (Supply Chain): 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any situation referred to in Regulation 58 of the Public Contracts (Scotland) Regulations 2015.
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
AND
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
AND
(c) Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark.
AND
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the T…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP47822 Multiple Sclerosis Medicines” is a framework: the contest is a place on its panel, up to 6 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 31 Oct 2022, 16:12 GMT
- Last source update
- 15 Feb 2023, 14:13 GMT
- Award evaluation window
- 1 Dec 2022 – …
- FTS notice number
2023/S 000-004666- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-037dcaFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated values referred to in Section II.1.5 and 11.2.6 covers the twenty-six (26) months' contract duration and the twenty-two (22) months' extension period of the Framework Agreement. For further details of individual lines for the Products awarded to the Framework Agreement, please contact the named person at the head of this Notice. (SC Ref:721538)
How it was run
Official notice- Appointment period ends
- 1 Dec 2022, 12:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 1 Dec 2022, 12:00 GMT
Timeline
1 Dec 2022 → 15 Feb 2023 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown1 Dec 2022, 12:00 GMT
- Bids opened1 Dec 2022, 12:00 GMT
- Notice published15 Feb 2023, 14:13 GMT
Notice history
2 events · 2 releases on Find a Tender · since 15 Feb 2023- Status changed to complete15 Feb 2023, 14:13 GMT
- Buyer details updated15 Feb 2023, 14:13 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Contract 004666-2023-1
- Signed
- 17 Jan 2023
- Value
- £12,985,684
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 4bids · 4 electronic · 4 from abroad | 0 | — | — |
Contracting authority & participating public bodies
2 public bodies on the noticeConsortium members and other public bodies
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Contracting authorityCentral purchasing bodyBody governed by public lawHealth
Dispute resolution & review bodies
- Sheriff Court HouseReview body
- Sherriff Court HouseReview body
Framework contractors & participating bidders
4 commercial parties on the notice- Biogen Idec LtdFramework contractor
- Merck Serono LimitedFramework contractor
- MylanFramework contractor
- Teva UK LimitedFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.